GB201600271D0 - Bacterial vaccine - Google Patents

Bacterial vaccine

Info

Publication number
GB201600271D0
GB201600271D0 GBGB1600271.9A GB201600271A GB201600271D0 GB 201600271 D0 GB201600271 D0 GB 201600271D0 GB 201600271 A GB201600271 A GB 201600271A GB 201600271 D0 GB201600271 D0 GB 201600271D0
Authority
GB
United Kingdom
Prior art keywords
bacterial vaccine
vaccine
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1600271.9A
Other versions
GB2530949A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Absynth Biologics Ltd
Original Assignee
Absynth Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absynth Biologics Ltd filed Critical Absynth Biologics Ltd
Publication of GB201600271D0 publication Critical patent/GB201600271D0/en
Publication of GB2530949A publication Critical patent/GB2530949A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0291—Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GB1600271.9A 2012-04-11 2013-04-09 Bacterial vaccine Withdrawn GB2530949A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1206366.5A GB201206366D0 (en) 2012-04-11 2012-04-11 Bacterial vaccine
GB1414131.1A GB2515669B (en) 2012-04-11 2013-04-09 Bacterial vaccine

Publications (2)

Publication Number Publication Date
GB201600271D0 true GB201600271D0 (en) 2016-02-24
GB2530949A GB2530949A (en) 2016-04-06

Family

ID=46177137

Family Applications (3)

Application Number Title Priority Date Filing Date
GBGB1206366.5A Ceased GB201206366D0 (en) 2012-04-11 2012-04-11 Bacterial vaccine
GB1600271.9A Withdrawn GB2530949A (en) 2012-04-11 2013-04-09 Bacterial vaccine
GB1414131.1A Expired - Fee Related GB2515669B (en) 2012-04-11 2013-04-09 Bacterial vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1206366.5A Ceased GB201206366D0 (en) 2012-04-11 2012-04-11 Bacterial vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1414131.1A Expired - Fee Related GB2515669B (en) 2012-04-11 2013-04-09 Bacterial vaccine

Country Status (8)

Country Link
US (1) US9610341B2 (en)
EP (1) EP2814505A1 (en)
AU (2) AU2013246715A1 (en)
CA (1) CA2870150A1 (en)
GB (3) GB201206366D0 (en)
IN (1) IN2014DN07270A (en)
NZ (1) NZ629535A (en)
WO (1) WO2013153372A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2189473A3 (en) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
GB0409559D0 (en) 2004-04-29 2004-06-02 Univ Sheffield Polypeptide
GB0505949D0 (en) 2005-03-23 2005-04-27 Univ Sheffield Polypeptides
SI2344523T1 (en) 2008-09-17 2016-06-30 Glaxosmithkline Biologicals S.A. Combination gas vaccines and therapeutics
GB0917685D0 (en) 2009-10-09 2009-11-25 Absynth Biologics Ltd Antigenic polypeptide

Also Published As

Publication number Publication date
US20150050312A1 (en) 2015-02-19
EP2814505A1 (en) 2014-12-24
CA2870150A1 (en) 2013-10-17
GB2515669A (en) 2014-12-31
IN2014DN07270A (en) 2015-04-24
GB201206366D0 (en) 2012-05-23
US9610341B2 (en) 2017-04-04
GB201414131D0 (en) 2014-09-24
WO2013153372A1 (en) 2013-10-17
AU2013246715A1 (en) 2014-09-18
GB2515669B (en) 2016-03-09
AU2018200750A1 (en) 2018-03-29
GB2530949A (en) 2016-04-06
NZ629535A (en) 2017-01-27

Similar Documents

Publication Publication Date Title
HK1207967A1 (en) Vaccine
EP2832859A4 (en) Diabetes-inducible bacterium
PL2647387T3 (en) Vaccine Composition
EP2889490A4 (en) Blower
EP2876161A4 (en) Vaccine
GB201223386D0 (en) Vaccine
IL231043A0 (en) Vaccine
ZA201500656B (en) Marker vaccine
HK1212919A1 (en) Wt1 vaccine wt1
GB201119999D0 (en) Vaccine
SG10201703558XA (en) Bacterial engineering
EP2829281A4 (en) Lps vaccine
EP2763699A4 (en) Vaccine
EP2771453A4 (en) Diatom-based vaccines
ZA201306245B (en) Combination vaccines
EP2822599A4 (en) Vaccine formulation
GB201120000D0 (en) Vaccine
GB201006324D0 (en) Vaccine
GB201202090D0 (en) Vaccine
GB201218407D0 (en) Adjuvants
GB2515669B (en) Bacterial vaccine
DK2846829T3 (en) Vaccine combinations
GB201106170D0 (en) Bacterial vaccine
GB201217321D0 (en) Vaccine
GB201210226D0 (en) Vaccine

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)